Cytochrome P450 inhibitors and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8513291
APP PUB NO 20130102643A1
SERIAL NO

13700730

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compounds having the general structural formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ANGION BIOMEDICA CORP51 CHARLES LINDBERGH BLVD UNIONDALE NY 11553

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jung, Dawoon Tenafly, US 64 569
Lim, Dong Sung Fair Lawn, US 29 198
Mishra, Rama K Chicago, US 31 210
Oehlen, Lambertus J W M Westbury, US 10 26
Panicker, Bijoy Holtsville, US 45 575
Tarrant, James G Lindenhurst, US 18 163
Zhu, Xiaokang Oakland Gardens, US 10 60

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 20, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00